Glytec said today that it won a fourth 510(k) clearance from the FDA for its insulin titration software, eGlycemic Management System featuring Glucommander.
The latest FDA nod applies to product enhancements derived from user feedback, the Waltham, Mass.-based company said, including a streamlined transition of inpatients from IV to subcutaneous therapy and more robust workflow capabilities.
Get the full story at our sister site, Drug Delivery Business News.
The post Glytec lands another 510(k) clearance for diabetes management software appeared first on MassDevice.